Human APIs Powder
- Respiratory Drugs Raw Material
- Antiviral Antibacterial
- Antipyretic Analgesics
- Antihistamine Drugs
- Antineoplastic
- Urinary System Drugs
- Endocrine System
- Other
Pharmaceutical
- Pharmaceutical intermediates
- Heterocyclic Compound
- OLED material intermediate
- Diphenylamine intermediates
- Nutritional Supplements
- Pharmaceutical raw materials
Medicine Excipients
Veterinary raw materials
Phone: 86-29-89601602
E-mail: sales21@interlgroup.com
Add: Fengcheng 2nd Road, Weiyang District, Xi'an, Shaanxi, China
HRK Factory Silodosin Raw Materials Powder on sale
Product Overview:
Silodoxin is an alpha-adrenergic receptor antagonist invented by Kissei Pharmaceutical Company in Japan, which has a very good effect on the treatment of urinary disorders associated with benign prostatic hyperplasia. The selective effect on urethra was 12 and 7.5 times higher than prazosin and Tamsulosin, respectively, and could significantly inhibit the prostate contraction induced by norepinephrine. It can inhibit bladder hyperactivity in a dose-dependent manner and increase the pressure threshold of bladder contraction in benign prostatic hypertrophy rats. These data suggest that cilodoxin, in addition to improving bladder function, may also be effective in relieving symptoms associated with benign prostatic hypertrophy.
HRK Factory Silodosin Raw Materials Powder on sale Attributes
CAS:160970-54-7
MF:C25H32F3N3O4
MW:495.53
EINECS:814-909-2
Specification: 99% min Silodosin Powder
Sample:Silodosin Powder
Packaging:1kg/bag, 25kg/drum
Brand: Henrikang
Appearance:white
Storage: Cool Dry Place
Shelf Life: 2 Years
Test Method: HPLC
HRK Factory Silodosin Raw Materials Powder on sale Details
Compared to its peers Prazosin and Tamsulosin, silodoxin is highly selective towards α1A-receptors located in the prostate and bladder neck, while its affinity for α1B- and α1D- receptors is not significant. It blocks the alpha1A-receptor at this site, relaxes smooth muscle, and leads to improved urine flow and reduced BPH symptoms.
Silodoxin binds more selectively to the α1A-receptor than to the cardiovasculary-associated α1b-receptor, maximizing activity to the target organ while minimizing potential effects on blood pressure.
Uses of Silodosin.
The α1-adrenergic receptor is a G protein-coupled receptor: by binding to its natural ligands norepinephrine and epinephrine, it activates phospholipase C and downstream signaling molecules, including inositol triphosphate and diglycerol. Eventually, intracellular calcium levels increase, so smooth muscle contracts.
Silodosin is an alpha1-adrenergic receptor antagonist with the highest selectivity for the alpha1a-adrenergic receptor subtype. By blocking the α1a-adrenergic receptor signaling pathway, silodoxin promotes relaxation of the prostate and urethral smooth muscle, thereby improving lower urinary tract symptoms such as urination. Silodoxin also targets the afferent nerves in the bladder, relieving symptoms of bladder overactivity and storage.
Preparation of Silodosin.
Product Method of Bulk Silodosin Powder.
